Dudediligence.

Myriad Genetics, Inc

MYGNNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$68,850

1 notice · 15,000 sh

Oct 2025 to Oct 2026

Reported ·

$66,900

1 sale · 5 buys · $722,223 bought

Oct 2025 to Sep 2026

The two figures cover different periods.

The one reported sale carries the 10b5-1 box. It is 0.02% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-06-08: Kumar Rashmi, Form 1442026-02-25: Phanstiel S. Louise, bought2026-03-09: Raha Samraat S., bought2026-05-14: Bisaro Paul, bought2026-06-08: Kumar Rashmi, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-06-08Kumar Rashmi, Director$68,850
15,000 shplan 2025-11-19144 ↗
Form 4, 2026-06-09: sold 15,000 at $4.46 Form 4 ↗